Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Ephedrine treatment in DOK7 CM...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Ephedrine treatment in DOK7 CMS and investigation of potential mechanisms
Bibliographic Details
Main Authors:
Cossins, J
,
Lashley, D
,
Spearman, H
,
Maxwell, S
,
Palace, J
,
Robb, S
,
Beeson, D
Format:
Conference item
Published:
2010
Holdings
Description
Similar Items
Staff View
Similar Items
Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
by: Lashley, D, et al.
Published: (2010)
EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA
by: Lashley, D, et al.
Published: (2009)
Clinical features of the DOK7 neuromuscular junction synaptopathy.
by: Palace, J, et al.
Published: (2007)
The spectrum of mutations that underlie the DOK7 neuromuscular junction synaptopathy, and the patient response to treatment
by: Beeson, D, et al.
Published: (2012)
The effect of dok-7 on acetylcholine receptor clustering in C2C12 cells
by: Spearman, H, et al.
Published: (2008)